Cleared Traditional

K923510 - ALT (GPT) - ALANINE AMINOTRANSFERASE

K923510 is an FDA 510(k) clearance for ALT (GPT) - ALANINE AMINOTRANSFERASE, manufactured by Randox Laboratories, Ltd.. The device is a Class 1 Chemistry device with product code CKA cleared through the Traditional 510(k) pathway after a 124-day FDA review.

K923510 · Randox Laboratories, Ltd. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1992
Decision
124d
Days
Class 1
Risk

K923510 is an FDA 510(k) clearance for the ALT (GPT) - ALANINE AMINOTRANSFERASE. Classified as Nadh Oxidation/nad Reduction, Alt/sgpt (product code CKA), Class I - General Controls.

Submitted by Randox Laboratories, Ltd. (Antrim, N. Ireland, IR). The FDA issued a Cleared decision on November 16, 1992 after a review of 124 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1030 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Randox Laboratories, Ltd. devices

FDA 510(k) Submission Details - K923510

510(k) Number K923510 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 15, 1992
Decision Date November 16, 1992
Days to Decision 124 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
36d slower than avg
Panel avg: 88d · This submission: 124d
Pathway characteristics
Predicate-based equivalence.

CKA Device Classification - Class 1, General Controls

Product Code CKA Nadh Oxidation/nad Reduction, Alt/sgpt
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1030
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CKA Nadh Oxidation/nad Reduction, Alt/sgpt

All 117
Devices cleared under the same product code (CKA) and FDA review panel - the closest regulatory comparables to K923510.
ALANINE AMINOTRANSFERASE (ALT) TEST
K935180 · Em Diagnostic Systems, Inc. · Jan 1994
HEMOCARD HEMOGLOBIN E
K930070 · Isolab, Inc. · Apr 1993
OLYLMPUS ALANINE AMINOTRANSFERASE REAGENT
K925339 · Olympus Corp. · Feb 1993
ROCHE REAGENT FOR ALT
K924245 · Roche Diagnostic Systems, Inc. · Oct 1992
EMDS ALANINE AMINOTRANSFER TEST(ALT) TECH RA 1000
K923257 · Em Diagnostic Systems, Inc. · Sep 1992
IL TEST ALT, PN 35311
K923623 · Instrumentation Laboratory CO · Sep 1992